Frontiers in Cancer Biotechnology Research

Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.

Research Articles

Unlocking Rare Cancers: The Breakthrough Bispecific Antibody Targeting NRG1 Fusions

Breakthrough research on zenocutuzumab, a bispecific antibody targeting NRG1 fusion-positive cancers, with results from the eNRGy trial showing promising outcomes across multiple tumor types.

Elijah Foster
Aug 09, 2025

Popular Articles